Primary Site >> Colorectal Cancer
Gene >> HLA-G
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Increased expression of human histocompatibility leukocyte antigen-G in colorectal cancer cells. PMID: 9855710 |
Ref: Identification of 4 different alternatively spliced HLA-A transcripts. PMID: 10551420 |
Ref: Expression of the non-classical HLA-G antigen in tumor cell lines is extremely restricted. PMID: 11263857 |
Ref: No expression of human leukocyte antigen G (HLA-G) in colorectal cancer cells. PMID: 15521238 |
Ref: HLA-G upregulation in pre-malignant and malignant lesions of the gastrointestinal tract. PMID: 15722570 |
Ref: Human leukocyte antigen G expression: as a significant prognostic indicator for patients with colorectal cancer. PMID: 17277760 Ref: Expression of human leukocyte antigen G (HLA-G) correlates with poor prognosis in gastric carcinoma. PMID: 17564748 Ref: Expression of human leucocyte antigen G (HLA-G) is associated with prognosis in non-small cell lung cancer. PMID: 17673327 |
Ref: Plasma soluble HLA-G is a potential biomarker for diagnosis of colorectal, gastric, esophageal and lung cancer. PMID: 21726203 |
Ref: Combined analysis of HLA class I, HLA-E and HLA-G predicts prognosis in colon cancer patients. PMID: 24196788 Ref: Inhibition of host immune response in colorectal cancer: human leukocyte antigen-G and beyond. PMID: 24744572 Ref: Prognostic value of HLA class I, HLA-E, HLA-G and Tregs in rectal cancer: a retrospective cohort study. PMID: 24997850 |
Ref: Predictive value of HLA-G and HLA-E in the prognosis of colorectal cancer patients. PMID: 25461612 |
Ref: Association of the HLA-G 3'UTR polymorphisms with colorectal cancer in Italy: a first insight. PMID: 26752414 Ref: HLA-G and classical HLA class I expression in primary colorectal cancer and associated liver metastases. PMID: 26968946 Ref: Promoter methylation and mRNA expression of HLA-G in relation to HLA-G protein expression in colorectal cancer. PMID: 27245757 Ref: A comparison of cancer stem cell markers and nonclassical major histocompatibility complex antigens in colorectal tumor and noncancerous tissues. PMID: 27806848 |
Ref: Soluble HLA-G is a differential prognostic marker in sequential colorectal cancer disease stages. PMID: 28233298 Ref: Importance of the plasma soluble HLA-G levels for prognostic stratification with traditional prognosticators in colorectal cancer. PMID: 28415627 Ref: HLA-G 3'UTR Polymorphisms Predict Drug-Induced G3-4 Toxicity Related to Folinic Acid/5-Fluorouracil/Oxaliplatin (FOLFOX4) Chemotherapy in Non-Metastatic Colorectal Cancer. PMID: 28653974 Ref: Predictive value of different proportion of lesion HLA-G expression in colorectal cancer. PMID: 29296176 |
Ref: HLA-G protein expression in colorectal cancer evaluated by immunohistochemistry and western blot analysis: Its expression characteristics remain enigmatic. PMID: 30006120 Ref: Clinical Significance of Potential Unidentified HLA-G Isoforms Without alpha1 Domain but Containing Intron 4 in Colorectal Cancer Patients. PMID: 30234020 Ref: HLA-G Expression in Tumor Tissues and Soluble HLA-G Plasma Levels in Patients with Gastrointestinal Cancer PMID: 30360598 |